Rachel Burnside is a cytogenetics laboratory director in the department of Pathology at the University of Florida. Prior to her academic role, Dr. Burnside was a cytogenetics director for LabCorp in North Carolina for 10 years, and has worked in industry, leading product management and global marketing teams for Beckman Coulter Diagnostics from 2018 to 2022. Dr. Burnside's lab at UF primarily specializes in hematological malignancies. Her scholarly interests include medical genetics education, and she has presented her work at national conferences (including this meeting). She is a course director for the medical genetics course at UF's medical school, and is enthusiastic about introducing students at all levels to laboratory genetics and clinical laboratory science as a career.